Qi Wang

机构：Tongji University, The University of Texas MD Anderson Cancer Center, Harbin Medical University, Shanxi University, Capital Medical University, Anhui Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Wenzhou Medical University, Soochow University, Third Affiliated Hospital of Guangzhou Medical University, Xinjiang Institute of Materia Medica, Nanjing Brain Hospital, Shandong Provincial Hospital, Third People's Hospital of Hangzhou, Shanghai Pulmonary Hospital, Jiangsu Provincial Institute of Geological Survey, First Affiliated Hospital of Anhui Medical University, Northern Jiangsu People's Hospital, Nanjing Surveying and Mapping Research Institute (China), Institute of Hematology & Blood Diseases Hospital, Beijing Ditan Hospital, Shandong First Medical University, Yangzhou University, Nanjing Medical University, Guangzhou Medical University, Xinjiang University · ORCID：0000-0003-0858-9393

发表论文 404 篇 · 总被引 4515 次 · h-index 29

代表论文

• IGF2BP3 regulates EMP1 stability in an m6A-dependent manner and activates the TGF-β pathway to promote pancreatic cancer invasion (2025 · Cell Death and Disease · 被引 3)
• M6A-ALKBH5-dependent RBMS3-AS3 down-regulation suppresses ferroptosis to promote lung adenocarcinoma progression through HNRNPDL/ZEB1/GPX4 axis (2025 · npj Precision Oncology · 被引 1)
• Supplementary Figure S6 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC (2025)
• Supplementary Table S3 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC (2025)
• Supplementary Figure S8 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC (2025)
• Supplementary Table S1 from Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC (2025)